In The News
Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations
December 25, 2019
Background and Purpose Liquid embolic agents (LEAs) are the determinant tool for successful embolization of cranial arteriovenous shunts. There are few currently available LEAs.
In The News
MeRes100 BRS, the first bioresorbable vascular matrix to treat coronary artery disease
December 25, 2019
MeRes100 BRS - the first thin-tip sirolimus releasing bioresorbable vascular matrix - shows positive long-term safety consistent with low cardiac event rates and zero matrix stent thrombosis for patients with coronary artery disease
In The News
About Our Heritage From Experts
October 11, 2019
When words are both true and kind, they can change the world. Experts Speak…
ABOUT
Founded in 2006, Meril is an India-based global medical device company that is dedicated to the innovation, design and development of novel, clinically relevant and state-of-the-art devices
LEARN MORE
Latest Blog
